ITEM VIEW

Education and training for medicines development, regulation, and clinical research in emerging countries

dc.contributor.authorKerpel-Fronius, Sandoren_ZA
dc.contributor.authorRosenkranz, Bernden_ZA
dc.contributor.authorAllen, Elizabethen_ZA
dc.contributor.authorBass, Rolfen_ZA
dc.contributor.authorMainard, Jacques D.en_ZA
dc.contributor.authorDodoo, Alexen_ZA
dc.contributor.authorDubois, Dominique J.en_ZA
dc.contributor.authorHela, Mandisaen_ZA
dc.contributor.authorKern, Stevenen_ZA
dc.contributor.authorMassud, Joaoen_ZA
dc.contributor.authorSilva, Honorioen_ZA
dc.contributor.authorWhitty, Jeremyen_ZA
dc.date.accessioned2016-11-15T07:28:54Z
dc.date.available2016-11-15T07:28:54Z
dc.date.issued2015
dc.identifier.citationKerpel-Fronius, S., et al. 2015. Education and training for medicines development, regulation, and clinical research in emerging countries. Frontiers in Pharmacology, 6:80, doi:10.3389/fphar.2015.00080
dc.identifier.issn1663-9812 (online)
dc.identifier.otherdoi:10.3389/fphar.2015.00080
dc.identifier.urihttp://hdl.handle.net/10019.1/99853
dc.descriptionCITATION: Kerpel-Fronius, S., et al. 2015. Education and training for medicines development, regulation, and clinical research in emerging countries. Frontiers in Pharmacology, 6:80, doi:10.3389/fphar.2015.00080.
dc.descriptionThe original publication is available at www.frontiersin.org
dc.description.abstractThe aim of this satellite workshop held at the 17th World Congress of Basic and Clinical Pharmacology (WCP2014) was to discuss the needs, optimal methods and practical approaches for extending education and teaching of medicines development, regulation, and clinical research to Low and Middle Income Countries (LMICs). It was generally agreed that, for efficiently treating the rapidly growing number of patients suffering from non-communicable diseases, modern drug therapy has to become available more widely and with a shorter time lag in these countries. To achieve this goal many additional experts working in medicines development, regulation, and clinical research have to be trained in parallel. The competence-oriented educational programs designed within the framework of the European Innovative Medicine Initiative-PharmaTrain (IMI-PhT) project were developed with the purpose to cover these interconnected fields. In addition, the programs can be easily adapted to the various local needs, primarily due to their modular architecture and well defined learning outcomes. Furthermore, the program is accompanied by stringent quality assurance standards which are essential for providing internationally accepted certificates. Effective cooperation between international and local experts and organizations, the involvement of the industry, health care centers and governments is essential for successful education. The initiative should also support the development of professional networks able to manage complex health care strategies. In addition it should help establish cooperation between neighboring countries for jointly managing clinical trials, as well as complex regulatory and ethical issues.en_ZA
dc.description.urihttp://journal.frontiersin.org/article/10.3389/fphar.2015.00080
dc.format.extent8 pages
dc.language.isoen_ZAen_ZA
dc.publisherFrontiers Media
dc.subjectPharmaceutical medicineen_ZA
dc.subjectNon-communicable diseases -- Drug therapyen_ZA
dc.subjectClinical trialsen_ZA
dc.subjectPharmacy -- Researchen_ZA
dc.titleEducation and training for medicines development, regulation, and clinical research in emerging countriesen_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's version
dc.rights.holderAuthors retain copyright


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW